Averaging cannot be used in cases when testing is intended to measure variability within the product, such as powder blend/mixture uniformity or dosage form content uniformity. In the context of additional testing performed during an OOS investigation, averaging the result(s) of the original test that ed the investigation and additional retest or resample results obtained during the OOS investigation is not appropriate because it hides variability among the individual results.